ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daviskas, E
Right arrow Articles by Seale, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daviskas, E
Right arrow Articles by Seale, J.
Eur Respir J 1996; 9: 716-724
Copyright © ERS Journals Ltd 1996


Original Articles

Mucociliary clearance during and after isocapnic hyperventilation with dry air in the presence of frusemide

E Daviskas, SD Anderson, I Gonda, D Bailey, G Bautovich, and JP Seale

We have previously shown that mucociliary clearance (MCC) decreased during and increased after isocapnic hyperventilation (ISH) with dry air, both in asthmatic and healthy subjects. Inhaled frusemide, an inhibitor of the Na+/K+/2Cl- and NaCl co-transporters on the basolateral membrane of the epithelial cell, prevents the airway narrowing provoked by ISH with dry air. The co-transport system controls epithelial cell volume and chloride secretion and, thus, frusemide has the potential to modify the rate of recovery of periciliary fluid volume during and after ISH with dry air, and hence affect MCC. Frusemide also blocks mediator release from mast cells, which may also modify the increase in MCC after ISH. Eleven asthmatic and 11 healthy subjects inhaled frusemide (35.7 +/- 0.44 mg) or its vehicle, from a Fisoneb ultrasonic nebulizer 30 min before ISH with dry air, on two separate occasions. MCC was measured using 99mTc-sulphur colloid and a gamma camera. Frusemide, compared to its vehicle, did not affect MCC during or 45 min after ISH. However, in the presence of frusemide, the onset of the increase of MCC after ISH was significantly delayed for approximately 10 min in the whole right lung (p < 0.002) and central region (p < 0.01) in the asthmatic but not in the healthy subjects. These findings could be explained by frusemide delaying the recovery of the periciliary fluid volume after ISH with dry air and/or interfering with the stimulus that causes the increase in MCC in the asthmatic subjects after ISH.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. S. Davis, E. Daviskas, S. D. Anderson, C. Kotaru, R. B. Hejal, J. H. Finigan, A. J. Coreno, M. E. Skowronski, L. Brianas, and E. R. McFadden Jr.
Airway surface fluid desiccation during isocapnic hyperpnea
J Appl Physiol, June 1, 2003; 94(6): 2545 - 2547.
[Full Text] [PDF]


Home page
ChestHome page
A. S. Niven and G. Argyros
Alternate Treatments in Asthma
Chest, April 1, 2003; 123(4): 1254 - 1265.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. T. Chen and D. B. Yeates
Ion transport and regulation of respiratory tract fluid output in dogs
J Appl Physiol, March 1, 2001; 90(3): 821 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. L. Winters and D. B. Yeates
Interaction between ion transporters and the mucociliary transport system in dog and baboon
J Appl Physiol, October 1, 1997; 83(4): 1348 - 1359.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.